Opthea Raises A$55.9M in Retail Entitlement Offer

Ticker: OPTEY · Form: 6-K · Filed: Jul 15, 2024 · CIK: 1815620

Sentiment: bullish

Topics: capital-raise, entitlement-offer, clinical-development

TL;DR

Opthea just closed a A$55.9M retail offer, boosting cash for drug development.

AI Summary

Opthea Limited announced the results of its retail entitlement offer, raising A$55.9 million (US$36.9 million). The offer, which closed on July 15, 2024, saw strong participation from eligible retail shareholders. These funds will be used to advance Opthea's clinical programs.

Why It Matters

This capital raise provides Opthea with crucial funding to continue the development of its novel therapies, potentially impacting future treatments for eye diseases.

Risk Assessment

Risk Level: medium — While the capital raise is positive, the company is still in clinical development, which carries inherent risks.

Key Numbers

Key Players & Entities

FAQ

What was the total amount raised in the retail entitlement offer?

Opthea Limited announced it raised A$55.9 million (US$36.9 million) in its retail entitlement offer.

When did the retail entitlement offer close?

The retail entitlement offer closed on July 15, 2024.

What is the primary purpose of the funds raised?

The funds raised will be used to advance Opthea's clinical programs.

What is Opthea Limited's SIC code?

Opthea Limited's Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).

What form does Opthea Limited file annually?

Opthea Limited files its annual reports under cover of Form 20-F.

Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-07-15 06:06:32

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. OPTHEA LIMITED (Registrant) By: /s/ Frederic Guerard Name: Frederic Guerard Title: Chief Executive Officer Date: 07/15/2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing